81°
Feels Like: 84°
83°
66°
78°
By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to...
Read More »By Ben Hirschler and Tom Bill LONDON (Reuters) - AstraZeneca is closing in on a site for its new $500 million home in Cambridge, wit...
Read More »By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc ...
Read More »(Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a lat...
Read More »By Toni Clarke (Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at...
Read More »(Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage tri...
Read More »By Caroline Humer (Reuters) - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy...
Read More »
By Padraic Halpin DUBLIN (Reuters) - Elan announced its second major drug deal inside a week on Monday and said it would buy back mo...
Read More »
By Dorene Internicola NEW YORK (Reuters) - Fitness experts are shining a new light on group classes from Zumba to yoga because they ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Boys who are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in elemen...
Read More »
